Intense red upconversion emission of Yb/Tm/Ho triply-doped tellurite glasses.
By conventional melting and quenching methods, 3Yb2O3-0.2Tm2O3-xHo2O3 (wt%, x=0.2~1.2) was doped into an easily fiberized tellurite glass with composition of 78TeO2-10ZnO-12Na2O (mol%) to form YTH-TZN78 glasses. Under 976 nm excitation, the direct sensitizing effect of Yb ions (Yb→Ho) and indirect sensitizing and self-depopulating effects of Tm ions (Yb→Tm→Ho) were found to present intense red upconversion emission at 657 nm (Red, Ho:5F5→5I8) and were responsible for the absence of the usually observed 484 nm emission (Blue, Tm:1G4→3H36). Regardless of the dopant concentration of Ho ions, the intensity of the red emission at 657 nm (Red, Ho:5F5→5I8) is about three times stronger than that of the green one at 543 nm (Green, Ho:5S2→5I8). For this certain red emission at 657 nm, 0.4 wt% Ho2O3-doped YTH-TZN78 glass was found to present the highest emission intensity and is therefore determined as a promising active tellurite glass for red fiber laser development.
Judd–Ofelt analysis, frequency upconversion, and infrared photoluminescence of Ho3+-doped and Ho3+/Yb3+-codoped lead bismuth gallate oxide glasses
Ho3+-doped and Ho3+/Yb3+-codoped lead bismuth gallate (PBG) oxide glasses were prepared and their spectroscopic properties were investigated. The derived Judd–Ofelt intensity parameters (Ω2=6.81×10−20 cm2, Ω4=2.31×10−20 cm2, and Ω6=0.67×10−20 cm2) indicate a higher asymmetry and stronger covalent environment for Ho3+ sites in PBG glass compared with those in tellurite, fluoride (ZBLAN), and some other lead-contained glasses. Intense frequency upconversion emissions peaking at 547, 662, and 756 nm as well as infrared emissions at 1.20 and 2.05 μm in Ho3+/Yb3+-codoped PBG glass were observed, confirming that energy transfer between Yb3+ and Ho3+ takes place, and a two-phonon-assisted energy transfer from Yb3+ to Ho3+ ions was determined by the calculation using phonon sideband theory. The 1.20 μm emission observed was primarily due to the weak multiphonon deexcitation originated from the small phonon energy of PBG glass (∼535 cm−1). A large product of emission cross-section and measured lifetime (9.93×10−25...
Atomistic insight into novel co-delivery of doxorubicin and paclitaxel using fullerene modified by dimethyl acrylamide trimethyl chitosan: A computational study

 Background: The distribution of drugs could not be controlled in the conventional drug delivery system. This has led to the development of a smart nanoparticle-based drug delivery system, known as smart drug delivery systems. In cancer research, novel biocompatible nanocarriers have received much attention for various ranges of anticancer drugs.In the current study, the effect of a novel co-polymer "dimethyl acrylamide-trimethyl chitosan" was investigated on drug delivery of doxorubicin and paclitaxel utilizing modified fullerene nanocarrier. This study was performed via molecular dynamics simulation based on acidic pH sensitivity of the cancer microenvironment. Furthermore, hydrogen bonds, diffusion coefficient, gyration radius, and drug-carrier interaction energies were investigated here. Interestingly, a simultaneous pH and temperature-sensitive system was proposed for paclitaxel and doxorubicin for a co-polymer. A pH-sensitive and temperature-sensitive copolymer was used based on trimethyl chitosan and dimethyl acrylamide, respectively. In such a dualistic approach, co-polymer makes an excellent option to have two properties in one bio-polymer. Results: The results suggest the dramatic and indisputable role of the co-polymer in the release of doxorubicin and paclitaxel in cancerous tissues, as well as an increased biocompatibility and drug uptake in a neutral state. The validation test was performed by repeated simulations of a similar article. The results are very close to those of the reference paper .Conclusions: Overall, conjugated fullerene and dimethyl acrylamide-trimethyl chitosan (DMAA-TMC) as carriers can be a good proposition for loading, delivery, and release of anti-cancer drugs based on a pH/temperature-sensitive smart drug delivery system.